Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
11/2014
11/25/2014US8895020 Single chain trimers and uses therefor
11/25/2014US8895019 Biofilm treatment
11/25/2014US8895018 Recombinant T-cell receptor ligand for the treatment of cognitive and neuropsychiatric impairment induced by substance addiction
11/25/2014US8895017 HER-2 peptides and vaccines
11/25/2014US8895016 Antagonists of activin-actriia and uses for increasing red blood cell levels
11/25/2014US8895015 Norovirus capsid and rotavirus VP6 protein for use as combined vaccine
11/25/2014US8895014 Bioconjugates made from recombinant N-glycosylated proteins from procaryotic cells
11/25/2014US8895011 Insulin-resistance-improving drug
11/25/2014US8895010 Antibody polypeptides that antagonize CD40L
11/25/2014US8895009 Purified antibody composition
11/25/2014US8895008 Compositions and methods relating to anti-IGF-1 receptor antibodies
11/25/2014US8895007 Antibodies which bind to the human CC chemokine receptor 4 and uses thereof
11/25/2014US8895006 Ricin ribosome binding protein compositions and methods of use thereof
11/25/2014US8895005 Therapeutic agent
11/25/2014US8895004 Method for the treatment of amyloidoses
11/25/2014US8895003 Pharmaceutical composition comprising EDA-1 Fusion Protein
11/25/2014US8895001 Use of ErbB3 inhibitors in the treatment of triple negative and basal-like breast cancers
11/25/2014US8895000 Methods for inhibiting the binding of endosialin to ligands
11/25/2014US8894999 Use of DR6 and p75 antagonists to promote survival of cells of the nervous system
11/25/2014US8894998 Antibodies directed to αVβ6 and uses thereof
11/25/2014US8894997 Monoclonal antibodies to influenza H1N1 virus uses thereof
11/25/2014US8894996 Immunoadjuvant composition and use thereof
11/25/2014US8894995 Method of treating a disorder or condition of viral etiology
11/25/2014US8894990 Method for treating psoriatic arthritis by administering an anti-IL-12 antibody
11/25/2014US8894973 Method and system for differential diagnosis of chronic schizophrenia and chronic alcoholism
11/20/2014US20140342405 Vascular endothelial growth factor 2
11/20/2014US20140341982 Vaccination With Immuno-Isolated Cells Producing An Immunomodulator
11/20/2014US20140341980 Method to Enhance an Immune Response of Nucleic Acid Vaccination
11/20/2014US20140341978 Cancer immunotherapy
11/20/2014US20140341974 Liposomal Vaccine Adjuvants and Methods of Making and Using Same
11/20/2014US20140341971 Composition for targeting dendritic cells
11/20/2014US20140341970 Vaccine composition containing synthetic adjuvant
11/20/2014US20140341951 Method of treatment employing therapeutic t cell product from mobilised donors
11/20/2014US20140341950 Recombinant avian paramyxovirus vaccine and method for making and using thereof
11/20/2014US20140341949 Vaccine
11/20/2014US20140341948 Attenuated negative strand viruses with altered interferon antagonist activity for use as vaccines and pharmaceuticals
11/20/2014US20140341947 Immunogenic compositions comprising lawsonia intracellularis
11/20/2014US20140341946 Use of a modified poxvirus for the rapid induction of immunity against a poxvirus or other infectious agents
11/20/2014US20140341945 Delamination resistant pharmaceutical glass containers containing active pharmaceutical ingredients
11/20/2014US20140341944 Proteins comprising mrsa pbp2a and fragments thereof, nucleic acids encoding the same, and compositions and their use to prevent and treat mrsa infections
11/20/2014US20140341940 Immunomodulator for the treatment of cancerous tumors in the epithelial tissue lining surfaces inside or outside body organs
11/20/2014US20140341939 Modification of helper t cell-inducing polypeptide
11/20/2014US20140341936 Novel Clostridium Difficile DNA Vaccine
11/20/2014US20140341932 Novel pepetides
11/20/2014US20140341931 Soluble cd27 (scd27) and the use thereof
11/20/2014US20140341929 Human binding molecules capable of binding to and neutralizing influenza b viruses and uses thereof
11/20/2014US20140341926 Method for egfr directed combination treatment of cancer
11/20/2014US20140341925 Formulation of human antibodies for treating tnf-alpha associated disorders
11/20/2014US20140341924 Formulation of human antibodies for treating tnf-alpha associated disorders
11/20/2014US20140341923 Human Rhinovirus (HRV) Antibodies
11/20/2014US20140341922 Method for Overcoming Tolerance to Targeted Anti-Cancer Agent
11/20/2014US20140341918 Vaccine for Falciparum Malaria
11/20/2014US20140341917 Anti-pd-l1 antibodies and uses thereof
11/20/2014US20140341916 Therapeutic combinations and methods of treating melanoma
11/20/2014US20140341913 Methods and compositions for treating asthma using anti-il-13 antibodies
11/20/2014US20140341912 Monoclonal antibodies directed to cd52
11/20/2014US20140341911 Prevention and Treatment of Amyloidogenic Disease
11/20/2014US20140341909 Conjugation of biomolecules using diels-alder cycloaddition
11/20/2014US20140341905 Sparc binding scfvs
11/20/2014US20140341902 Methods of treating cancer using pd-1 axis binding antagonists and mek inhibitors
11/20/2014US20140341901 Compositions and methods of use for antibodies of dickkopf-1
11/20/2014US20140341900 Methods of treating cancer
11/20/2014US20140341894 Certain chemical entities, compositions and methods
11/20/2014US20140341893 Blood plasma biomarkers for bevacizumab combination therapies for treatment of breast cancer
11/20/2014US20140341892 Anti-alpha2 integrin antibodies and their uses
11/20/2014US20140341890 Delamination resistant pharmaceutical glass containers containing active pharmaceutical ingredients
11/20/2014US20140341886 TREATMENT WITH ANTI ErbB2 ANTIBODIES
11/20/2014US20140341844 Immunocytokines in combination with anti-erbb antibodies for the treatment of cancer
11/20/2014US20140341815 Delivery system for remote treatment of an animal
11/20/2014US20140341810 Antagonists for abdominal vasopressin v2 receptor and uses thereof
11/20/2014US20140341802 Provasopressin antagonists and uses thereof
11/20/2014US20140341801 Inactivation of smooth muscle tissue
11/18/2014US8889847 Antibodies and immunoconjugates and uses therefor
11/18/2014US8889845 Surrogate markers for viral infections and other inflammatory responses
11/18/2014US8889838 Removal of serine proteases by treatment with finely divided silicon dioxide
11/18/2014US8889641 Modified virus vectors and methods of making and using the same
11/18/2014US8889619 Fusion protein of Exendin-4 and its analog, preparation method and use thereof
11/18/2014US8889616 MUC1 based glycolipopeptide vaccine with adjuvant
11/18/2014US8889430 Nanostructures, methods of synthesizing thereof, and methods of use thereof
11/18/2014US8889362 Cell classification system
11/18/2014US8889181 Immunostimulatory compositions comprising liposome-encapsulated oligonucleotides and epitopes
11/18/2014US8889153 Combination of immunomodulator and anti-pathogenic agent
11/18/2014US8889152 Capsular polysaccharides solubilisation and combination vaccines
11/18/2014US8889151 Methods for treating headache
11/18/2014US8889150 Bacterial vaccine components from Staphylococcus aureus and uses thereof
11/18/2014US8889149 Use of flagellin to prevent and treat gram negative bacterial infection
11/18/2014US8889148 Flavivirus host-range mutations and uses thereof
11/18/2014US8889147 DNA vaccine against multitypes of avian influenza viruses and influenza virus-like particles comprising adjuvant-fused M2 protein
11/18/2014US8889146 Vaccine
11/18/2014US8889145 Immunogenic compositions of Staphylococcus aureus antigens
11/18/2014US8889144 PCSK9 vaccine
11/18/2014US8889143 Ii-key/HER-2/neu hybrid cancer vaccine
11/18/2014US8889142 Chlamydia trachomatis antigens for vaccine and diagnostic use
11/18/2014US8889141 T-cell receptor
11/18/2014US8889140 Compositions and methods for tissue repair
11/18/2014US8889138 Anti-ADDL antibodies and uses thereof
11/18/2014US8889137 Anti-HSV antibody
11/18/2014US8889136 Multiple-variable dose regimen for treating TNFα-related disorders
11/18/2014US8889135 Methods of administering anti-TNFα antibodies
11/18/2014US8889134 Modulators of Candida hyphal morphogenesis and uses thereof
1 ... 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 ... 1823